Guangdong Techpool Bio-Pharma, Nycomed deal

Nycomed acquired a 51.3% stake in Guangdong Techpool for about $210 million. Guangdong, which develops and manufactures biologics, markets Ulinastatin, a broad-acting trypsin inhibitor, to treat sepsi...